Literature DB >> 15379435

Pharmacokinetics of selamectin in dogs after topical application.

J Dupuy1, A L Derlon, J F Sutra, M C Cadiergues, M Franc, M Alvinerie.   

Abstract

Some pharmacokinetic parameters of selamectin were determined in male (n = 5) and female (n = 5) Beagle dogs following a topical application at a dose rate of 6 mg/kg. The plasma concentration versus time data for the drug were analysed using a one-compartment model. The maximum plasma concentrations of 12.72 +/- 5.13 ng/ml for males and 22.65 +/- 11.95 ng/ml for females occurred around 5 days after administration. The area under the concentration-time curve (AUC) was 192.08 +/- 63.85 ng.day/ml for males and 370.97 +/- 146.87 ng.day/ml for females. The mean residence time was the same in males and females (12.55 days). This study reveals a sex-influence on the disposition of selamectin in the plasma of dogs, which implies that further information will be needed for correlation with efficacy studies in dogs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15379435     DOI: 10.1023/b:verc.0000034993.87007.f8

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  11 in total

1.  Licking behaviour and environmental contamination arising from pour-on ivermectin for cattle.

Authors:  C M Laffont; M Alvinerie; A Bousquet-Mélou; P L Toutain
Journal:  Int J Parasitol       Date:  2001-12       Impact factor: 3.981

2.  Determination of selamectin in dog plasma by high performance liquid chromatography with automated solid phase extraction and fluorescence detection.

Authors:  J F Sutra; M C Cadiergues; J Dupuy; M Franc; M Alvinerie
Journal:  Vet Res       Date:  2001 Sep-Oct       Impact factor: 3.683

3.  Comparative pharmacokinetics of doramectin and ivermectin in cattle.

Authors:  P L Toutain; D W Upson; T N Terhune; M E McKenzie
Journal:  Vet Parasitol       Date:  1997-09       Impact factor: 2.738

Review 4.  Avermectins and milbemycins.

Authors:  Q A McKellar; H A Benchaoui
Journal:  J Vet Pharmacol Ther       Date:  1996-10       Impact factor: 1.786

5.  A pharmacokinetic analysis program (multi) for microcomputer.

Authors:  K Yamaoka; Y Tanigawara; T Nakagawa; T Uno
Journal:  J Pharmacobiodyn       Date:  1981-11

6.  Determination of moxidectin in plasma by high-performance liquid chromatography with automated solid-phase extraction and fluorescence detection.

Authors:  M Alvinerie; J F Sutra; M Badri; P Galtier
Journal:  J Chromatogr B Biomed Appl       Date:  1995-12-01

7.  Safety of selamectin in dogs.

Authors:  M J Novotny; M J Krautmann; J C Ehrhart; C S Godin; E I Evans; J W McCall; F Sun; T G Rowan; A D Jernigan
Journal:  Vet Parasitol       Date:  2000-08-23       Impact factor: 2.738

8.  Dose selection of selamectin for efficacy against adult fleas (Ctenocephalides felis felis) on dogs and cats.

Authors:  T L McTier; A D Jernigan; T G Rowan; M S Holbert; C D Smothers; B F Bishop; N A Evans; K A Gration; C J Giles
Journal:  Vet Parasitol       Date:  2000-08-23       Impact factor: 2.738

Review 9.  Sex-dependent metabolism of xenobiotics.

Authors:  C A Mugford; G L Kedderis
Journal:  Drug Metab Rev       Date:  1998-08       Impact factor: 4.518

Review 10.  Structure and activity of avermectins and milbemycins in animal health.

Authors:  W L Shoop; H Mrozik; M H Fisher
Journal:  Vet Parasitol       Date:  1995-09       Impact factor: 2.738

View more
  3 in total

1.  Haemaphysalis concinna (Acari: Ixodida): persistent efficacy of selamectin in Angora rabbits under laboratory conditions.

Authors:  Yao Bian; Guangyou Yang; Tao Wang; Jiagang Sun; Kaijun Li; Weizhong Chen
Journal:  Parasitol Res       Date:  2011-04-07       Impact factor: 2.289

2.  Use of selamectin and moxidectin in the treatment of mouse fur mites.

Authors:  Deborah M Mook; Kimberly A Benjamin
Journal:  J Am Assoc Lab Anim Sci       Date:  2008-05       Impact factor: 1.232

Review 3.  A review of the off-label use of selamectin (Stronghold/Revolution) in dogs and cats.

Authors:  Maggie A Fisher; David J Shanks
Journal:  Acta Vet Scand       Date:  2008-11-25       Impact factor: 1.695

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.